Key topics to cover during your consultation include: Your current diabetes control : Share recent HbA1c results, home blood glucose readings, and whether you are meeting your individualised glucose targets
Semaglutide, like its counterparts, can cause gastrointestinal issues, including nausea, vomiting, and diarrhea
The product information has been processed automatically, so it may contain errors
Retatrutide may ultimately prove equal or superior, but we do not have that evidence yet
In the phase 3 SELECT trial of Wegovy, the drug lowered major adverse cardiovascular events (MACEs) by 20%
Regular monitoring of kidney function via basic metabolic panel (electrolytes, creatinine, BUN) should occur every 36 months during the first year of therapy